Problems with immunosuppressive agents in renal disease.
D000818:Animals; D001379:Azathioprine / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007239:Infections / Q000209:etiology; D007248:Infertility, Male / Q000139:chemically induced; D007565:Jaundice / Q000139:chemically induced; D007674:Kidney Diseases / Q000188:drug therapy*; D016030:Kidney Transplantation; D007970:Leukopenia / Q000139:chemically induced; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008297:Male; D009369:Neoplasms / Q000209:etiology; D009402:Nephrosis, Lipoid / Q000188:drug therapy; D051381:Rats; D001745:Urinary Bladder Diseases / Q000139:chemically induced
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D001379:Azathioprine